AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Apr 29, 2011
30016_dirs_2011-04-29_f9b30b7b-7226-4bcd-b27c-14dc2c7d22a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-04-28
Reporting Person: Williams Michael J PhD (Corporate Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-28 | Common Stock | M | 7000 | $28.655 | Acquired | 16154 | Direct |
| 2011-04-28 | Common Stock | M | 3844 | $38.335 | Acquired | 19998 | Direct |
| 2011-04-28 | Common Stock | M | 1678 | $38.335 | Acquired | 21676 | Direct |
| 2011-04-28 | Common Stock | S | 12522 | $80.8954 | Disposed | 9154 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-28 | Non-Qualified Stock Option (right to buy) | $28.655 | M | 7000 | Disposed | 2015-02-02 | Common Stock (7000) | Direct |
| 2011-04-28 | Non-Qualified Stock Option (right to buy) | $38.335 | M | 3844 | Disposed | 2013-02-13 | Common Stock (3844) | Direct |
| 2011-04-28 | Incentive Stock Option (right to buy) | $38.335 | M | 1678 | Disposed | 2013-02-13 | Common Stock (1678) | Direct |
Footnotes
F1: Includes 89 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/31/2011.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $80.83 to $80.95, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock becomes exercisable as to 2,720 shares on 02/03/2006, 02/03/2007 and 2/3/2008, and the remaining 1,646 shares on 02/03/2009.
F4: Grant of options to buy shares of common stock becomes exercisable as to 1,106 shares on 02/14/2007, 1,104 shares on 02/14/2008 and 02/14/2009, and the remaining 530 shares on 02/14/2010.
F5: Grant of options to buy shares of common stock becomes exercisable as to 574 shares on 02/14/2010 and the remaining 1,104 shares on 02/14/2011.